Current advances in nanodrug delivery systems for malaria prevention and treatment

Linda N. Kekani, Bwalya A. Witika*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

5 Citations (Scopus)


Malaria is a life-threatening, blood-borne disease with over two hundred million cases throughout the world and is more prevalent in Sub-Saharan Africa than anywhere else in the world. Over the years, several treatment agents have been developed for malaria; however, most of these active pharmaceutical ingredients exhibit poor aqueous solubility and low bioavailability and may result in drug-resistant parasites, thus increasing malaria cases and eventually, deaths. Factors such as these in therapeutics have led to a better appreciation of nanomaterials. The ability of nanomaterials to function as drug carriers with a high loading capacity and targeted drug delivery, good biocompatibility, and low toxicity renders them an appealing alternative to conventional therapy. Nanomaterials such as dendrimers and liposomes have been demonstrated to be capable of enhancing the efficacy of antimalarial drugs. This review discusses the recent development of nanomaterials and their benefits in drug delivery for the potential treatment of malaria.

Original languageEnglish
Article number66
JournalDiscover Nano
Issue number1
Publication statusPublished - Dec 2023


  • Antimalarial activity
  • Drug delivery systems
  • Malaria
  • Nanomaterials
  • Solubility


Dive into the research topics of 'Current advances in nanodrug delivery systems for malaria prevention and treatment'. Together they form a unique fingerprint.

Cite this